The number of positive Covid-19 cases continues to rise in SA. Picture: 123rf.com/betonstudio
The Oxford vaccine produced an immune response in its first human trials, underlining its position as one of the leading candidates in the race to combat a virus that has led to hundreds of thousands of deaths and crippled the global economy. One option being explored would involve the US Food and Drug Administration awarding “emergency use authorisation” in October to the potential vaccine, the newspaper said.
The Financial Times reported that Washington was considering basing emergency approval of the vaccine on just a small UK study of about 10,000 people.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: